NeuroPace (NPCE) Share-based Compensation Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -4.08% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 12.94% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 26.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 59.09% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 31.63% |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | -13.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.25% |
| Dec 31, 2025 | 0.15% |
| Sep 30, 2025 | 1.43% |
| Jun 30, 2025 | 26.69% |
| Mar 31, 2025 | 3.39% |
| Dec 31, 2024 | 10.44% |
| Sep 30, 2024 | 7.02% |
| Jun 30, 2024 | -4.03% |
| Mar 31, 2024 | 19.53% |
| Dec 31, 2023 | 13.54% |
| Sep 30, 2023 | 10.95% |
| Jun 30, 2023 | 2.00% |
| Mar 31, 2023 | 42.81% |
| Dec 31, 2022 | 10.66% |
| Sep 30, 2022 | 97.11% |
| Jun 30, 2022 | 135.99% |
| Mar 31, 2022 | 636.63% |
| Dec 31, 2021 | 285.22% |
| Sep 30, 2021 | 267.77% |
| Jun 30, 2021 | 280.34% |
| Mar 31, 2021 | -32.89% |